Marta Ayala

1.1k total citations
36 papers, 754 citations indexed

About

Marta Ayala is a scholar working on Molecular Biology, Radiology, Nuclear Medicine and Imaging and Immunology. According to data from OpenAlex, Marta Ayala has authored 36 papers receiving a total of 754 indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Molecular Biology, 21 papers in Radiology, Nuclear Medicine and Imaging and 13 papers in Immunology. Recurrent topics in Marta Ayala's work include Monoclonal and Polyclonal Antibodies Research (20 papers), Glycosylation and Glycoproteins Research (12 papers) and Transgenic Plants and Applications (8 papers). Marta Ayala is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (20 papers), Glycosylation and Glycoproteins Research (12 papers) and Transgenic Plants and Applications (8 papers). Marta Ayala collaborates with scholars based in Cuba, United States and Thailand. Marta Ayala's co-authors include Jorge Gavilondo, Gertrudis Rojas, Boris Acevedo, Mónica Béquet‐Romero, M. Arias Rodríguez, Yanelys Morera Díaz, Yasser Perera, Marta Dueñas, Merardo Pujol and Freya Freyre and has published in prestigious journals such as Biochemical and Biophysical Research Communications, Trends in biotechnology and Gene.

In The Last Decade

Marta Ayala

35 papers receiving 712 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Marta Ayala Cuba 19 584 315 239 219 67 36 754
Michele C. Kieke United States 11 514 0.9× 528 1.7× 271 1.1× 173 0.8× 150 2.2× 14 827
Rosa M. F. Cardoso United States 13 687 1.2× 442 1.4× 404 1.7× 71 0.3× 97 1.4× 14 1.5k
Joost A. Kolkman Netherlands 14 580 1.0× 389 1.2× 165 0.7× 52 0.2× 109 1.6× 18 1.0k
Norbert Schülke United States 15 544 0.9× 306 1.0× 345 1.4× 38 0.2× 51 0.8× 16 1.1k
Helena Villanueva Spain 15 532 0.9× 116 0.4× 351 1.5× 133 0.6× 226 3.4× 28 867
Nigel Jenkins United Kingdom 20 1.2k 2.1× 407 1.3× 204 0.9× 189 0.9× 57 0.9× 43 1.5k
Regina A. Hodits Austria 8 810 1.4× 723 2.3× 162 0.7× 172 0.8× 72 1.1× 11 1.1k
Bernhard Valldorf Germany 12 387 0.7× 388 1.2× 141 0.6× 71 0.3× 120 1.8× 17 571
Jörg Willuda Switzerland 5 497 0.9× 644 2.0× 156 0.7× 60 0.3× 173 2.6× 5 864
R. Broeze United States 12 487 0.8× 114 0.4× 342 1.4× 79 0.4× 152 2.3× 24 841

Countries citing papers authored by Marta Ayala

Since Specialization
Citations

This map shows the geographic impact of Marta Ayala's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marta Ayala with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marta Ayala more than expected).

Fields of papers citing papers by Marta Ayala

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marta Ayala. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marta Ayala. The network helps show where Marta Ayala may publish in the future.

Co-authorship network of co-authors of Marta Ayala

This figure shows the co-authorship network connecting the top 25 collaborators of Marta Ayala. A scholar is included among the top collaborators of Marta Ayala based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marta Ayala. Marta Ayala is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Díaz, Yanelys Morera, Mónica Béquet‐Romero, Ana de la Torre, et al.. (2017). Specific humoral and cellular immune responses in cancer patients undergoing chronic immunization with a VEGF-based therapeutic vaccine. Vaccine. 35(28). 3582–3590. 24 indexed citations
2.
Delgado-Martínez, Rafael, Alexander Hernández, Yanelys Morera Díaz, et al.. (2017). Vaccine CIGB 247 is potentially safe for use as a novel therapeutic vaccine against cancer in Chlorocebus aethiops monkeys. International Immunopharmacology. 48. 55–60. 1 indexed citations
3.
4.
Gavilondo, Jorge, Amaury Pupo, Vivian Huerta, et al.. (2013). Affinity maturation and fine functional mapping of an antibody fragment against a novel neutralizing epitope on human vascular endothelial growth factor. Molecular BioSystems. 9(8). 2097–2106. 20 indexed citations
5.
Díaz, Yanelys Morera, et al.. (2011). Antigen dose escalation study of a VEGF-based therapeutic cancer vaccine in non human primates. Vaccine. 30(2). 368–377. 20 indexed citations
6.
7.
Pujol, Merardo, et al.. (2007). Fighting cancer with plant-expressed pharmaceuticals. Trends in biotechnology. 25(10). 455–459. 24 indexed citations
8.
Díaz, Yanelys Morera, et al.. (2006). Biologically active vascular endothelial growth factor as a bacterial recombinant glutathione S‐transferase fusion protein. Biotechnology and Applied Biochemistry. 44(1). 45–53. 17 indexed citations
9.
Acevedo, Boris, et al.. (2006). Fast and novel purification method to obtain the prostate specific antigen (PSA) from human seminal plasma. The Prostate. 66(10). 1029–1036. 12 indexed citations
10.
Rojas, Gertrudis, et al.. (2005). Efficient construction of a highly useful phage-displayed human antibody repertoire. Biochemical and Biophysical Research Communications. 336(4). 1207–1213. 11 indexed citations
11.
Pujol, Merardo, Marta Ayala, Jorge Gavilondo, et al.. (2004). An integral approach towards a practical application for a plant-made monoclonal antibody in vaccine purification. Vaccine. 23(15). 1833–1837. 35 indexed citations
12.
González, Luis Javier, Aniel Sánchez, Marta Ayala, et al.. (2004). Effect of high concentration of Co (II) on Enterobacter liquefaciens strain C‐1: A bacterium highly resistant to heavy metals with an unknown genome.. PROTEOMICS. 4(5). 1265–1279. 19 indexed citations
13.
Rodríguez, M. Arias, et al.. (2003). Transient expression of a full-size antibody against Hepatitis B surface antigen in plant cell suspension cultures. Biotecnología aplicada. 20(3). 152–154. 1 indexed citations
14.
Rodríguez, M. Arias, Marta Ayala, José A. Cremata, et al.. (2003). Expression and characterization of an anti‐(hepatitis B surface antigen) glycosylated mouse antibody in transgenic tobacco (Nicotiana tabacum) plants and its use in the immunopurification of its target antigen. Biotechnology and Applied Biochemistry. 38(3). 223–230. 41 indexed citations
15.
Acevedo, Boris, et al.. (2002). Development and validation of a quantitative ELISA for the measurement of PSA concentration. Clinica Chimica Acta. 317(1-2). 55–63. 91 indexed citations
16.
17.
18.
Dueñas, Marta, Marta Ayala, Mats Ohlin, et al.. (1995). A point mutation in a murine immunoglobulin V-region strongly influences the antibody yield in Escherichia coli. Gene. 158(1). 61–66. 19 indexed citations
19.
Coloma, M J, et al.. (1990). Specific Amplification of Rearranged Immunoglobulin Variable Region Genes from Mouse Hybridoma Cells. Hybridoma. 9(5). 407–417. 34 indexed citations
20.
Ayala, Marta, et al.. (1990). Cloning of the light and heavy chain variable regions of the anti-cd6 ior-t1 mouse monoclonal antibody using the polymerase chain reaction. Biotecnología aplicada. 7(3). 282–289. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Michele C. Kieke Breakdown of academic impact, for papers by Rosa M. F. Cardoso Breakdown of academic impact, for papers by Joost A. Kolkman Breakdown of academic impact, for papers by Norbert Schülke Breakdown of academic impact, for papers by Helena Villanueva Breakdown of academic impact, for papers by Nigel Jenkins Breakdown of academic impact, for papers by Regina A. Hodits Breakdown of academic impact, for papers by Bernhard Valldorf Breakdown of academic impact, for papers by Jörg Willuda Breakdown of academic impact, for papers by R. Broeze
Rankless by CCL
2026